Results 11 to 20 of about 7,196 (266)

Nanostructured Lipid Carriers (NLCs) for Oral Peptide Drug Delivery: About the Impact of Surface Decoration

open access: yesPharmaceutics, 2021
This study was aimed to evaluate the impact of surfactants used for nanostructured lipid carriers (NLCs) to provide enzymatic protection for incorporated peptides.
Iram Shahzadi   +3 more
doaj   +2 more sources

Preparation of NLCs-Based Topical Erythromycin Gel: In Vitro Characterization and Antibacterial Assessment

open access: yesGels, 2022
In the present study, erythromycin (EM)-loaded nanostructured lipid carriers (NLCs) were prepared by the emulsification and ultra-sonication method. EM-NLCs were optimized by central composite design using the lipid (A), pluronic F127 (B) and sonication ...
Ameeduzzafar Zafar   +8 more
doaj   +2 more sources

Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution

open access: yesPharmaceutics, 2018
As a platform for hepsin-specific drug delivery, we previously prepared IPLVVPLRRRRRRRRC peptide (RIPL)-conjugated nanostructured lipid carriers (RIPL-NLCs) composed of Labrafil® M 1944 CS (liquid oil) and Precirol® ATO 5 (solid lipid). In this
Chang Hyun Kim   +11 more
doaj   +2 more sources

Design, Development and Characterization of Nanostructure Lipid Carriers (NLCs) by HPH Method Loaded with Anticancer Drug [PDF]

open access: yes, 2023
The Nanostructured Lipid Carriers (NLCs) was formulated with the aim to improve the aqueous solubility and thus ultimately oral bioavailability of Axitinib. Axitinib loaded NLCs were formulated using Compritol ATO 888 as solid-lipid, Oleic acid as liquid-
Gorle, Ashish   +5 more
core   +1 more source

In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours [PDF]

open access: yes, 2023
Nanostructure lipid carriers (NLCs) were developed for the delivery of curmumin (CRN), a potent anticancer agent with low bioavailability, for the treatment of prostate cancer.
Giulia Getti   +5 more
core   +1 more source

QCD — NLC [PDF]

open access: yesAIP Conference Proceedings, 2005
10 pages, Talk given at Three Days of Hadronic Physics (HLPR04): Joint Meeting Heidelberg-Liege-Paris-Rostock, Liege, Belgium, 16-18 Dec 2004.
openaire   +3 more sources

EXPERIMENTAL DEVELOPMENT AND MOLECULAR DOCKING: NANOSTRUCTURED LIPID CARRIERS (NLCs) OF COENZYME Q10 USING STEARIC ACID AND DIFFERENT LIQUID LIPIDS AS LIPID MATRIX [PDF]

open access: yes, 2021
Objective: To develop coenzyme Q10 (co-Q10) nanostructured lipid carriers (NLCs) using stearic acid (SA) and various liquid lipids with different lipophilicity as well as highlights the use of in silico studies for predicting and elucidating the ...
RAHMASARI, FANNY PUTRI   +4 more
core   +2 more sources

Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers

open access: yesDrug Delivery, 2020
The oral delivery of amphotericin B (AmB) has remained a challenge due to its low solubility, permeability, and instability in gastric acidic pH. To solve these issues, herein, we reported a novel approach of using nanostructured lipid carriers (NLCs ...
Pataranapa Nimtrakul   +2 more
doaj   +1 more source

Augmented Oral Bioavailability and Prokinetic Activity of Levosulpiride Delivered in Nanostructured Lipid Carriers

open access: yesPharmaceutics, 2022
The present study is aimed to develop and optimize levosulpiride-loaded nanostructured lipid carriers (LSP-NLCs) for improving oral bioavailability and prokinetic activity of LSP.
Sadia Tabassam Arif   +7 more
doaj   +1 more source

On the relationship between NLC-width and linear NLC-width

open access: yesTheoretical Computer Science, 2005
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Frank Gurski, Egon Wanke
openaire   +3 more sources

Home - About - Disclaimer - Privacy